Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia

Waldenström macroglobulinemia (WM) is a rare form of non-Hodgkin B-cell lymphoma with a variable clinical presentation that can impact a patient’s quality of life by causing anemia, peripheral neuropathy, serum hyperviscosity, extramedullary disease, and other symptoms. There are several safe and ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz, Javier, Paludo, Jonas, Sarosiek, Shayna, Castillo, Jorge J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600142/
https://www.ncbi.nlm.nih.gov/pubmed/36291152
http://dx.doi.org/10.3390/cells11203287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600142/
https://www.ncbi.nlm.nih.gov/pubmed/36291152
http://dx.doi.org/10.3390/cells11203287

Ejemplares similares